Publications by authors named "Brian D Furmanski"

Claim this Profile
B
Biological activities of fusarochromanone: a potent anti-cancer agent.
Elahe Mahdavian, Phillip Palyok, Steven Adelmund, Tara Williams-Hart, Brian D Furmanski

BMC Res Notes· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinib.
Brian D Furmanski, Shuiying Hu, Ken-Ichi Fujita, Lie Li, Alice A Gibson

Clin Cancer Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
Hiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, Lie Li, Brian D Furmanski

J Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential uptake and selective permeability of fusarochromanone (FC101), a novel membrane permeable anticancer naturally fluorescent compound in tumor and normal cells.
Brian D Furmanski, Didier Dréau, Roy E Wuthier, John W Fuseler

Microsc Microanal· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis